1. Home
  2. ACH vs ABOS Comparison

ACH vs ABOS Comparison

Compare ACH & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACH

Accendra Health Inc.

N/A

Current Price

$3.52

Market Cap

217.5M

Sector

N/A

ML Signal

N/A

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.22

Market Cap

197.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACH
ABOS
Founded
1882
1996
Country
United States
United States
Employees
6500
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
217.5M
197.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ACH
ABOS
Price
$3.52
$2.22
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.38
$8.00
AVG Volume (30 Days)
667.9K
685.1K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.84
$1.19
52 Week High
$4.69
$3.60

Technical Indicators

Market Signals
Indicator
ACH
ABOS
Relative Strength Index (RSI) 54.97 41.66
Support Level $3.14 $2.18
Resistance Level $3.88 $2.43
Average True Range (ATR) 0.26 0.20
MACD 0.02 -0.05
Stochastic Oscillator 55.33 20.27

Price Performance

Historical Comparison
ACH
ABOS

About ACH Accendra Health Inc.

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: